Page 24 - JCBP-2-3

Journal of Clinical and
Basic Psychosomatics The antidepressant effect of ketamine

enhances visual sensory evoked potential long-term neurotransmitter response to ketamine treatment of major
potentiation in patients with major depressive disorder. Biol depressive disorder. Mol Psychiatry. 2016;21(3):320-327.
Psychiatry Cogn Neurosci Neuroimaging. 2020;5(1):45-55.
doi: 10.1038/mp.2015.83
doi: 10.1016/j.bpsc.2019.07.002
45. Chowdhury GM, Behar KL, Cho W, Thomas MA,
36. Armitage R, Hoffmann R, Trivedi M, Rush AJ. Slow- Rothman DL, Sanacora G. H-[ C]-nuclear magnetic
1
13
wave activity in NREM sleep: Sex and age effects in resonance spectroscopy measures of ketamine’s effect on
depressed outpatients and healthy controls. Psychiatry Res. amino acid neurotransmitter metabolism. Biol Psychiatry.
2000;95(3):201-213. 2012;71(11):1022-1025.
doi: 10.1016/s0165-1781(00)00178-5 doi: 10.1016/j.biopsych.2011.11.006
37. Duncan WC, Sarasso S, Ferrarelli F, et al. Concomitant 46. Milak MS, Rashid R, Dong Z, et al. Assessment of
BDNF and sleep slow wave changes indicate ketamine- relationship of ketamine dose with magnetic resonance
induced plasticity in major depressive disorder. Int J spectroscopy of Glx and GABA responses in adults with
Neuropsychopharmacol. 2013;16(2):301-311. major depression: A randomized clinical Trial. JAMA Netw
doi: 10.1017/S1461145712000545 Open. 2020;3(8):e2013211.

38. Duncan WC Jr., Selter J, Brutsche N, Sarasso S, Zarate CA doi: 10.1001/jamanetworkopen.2020.13211
Jr. Baseline delta sleep ratio predicts acute ketamine mood 47. Evans JW, Lally N, An L, et al. 7T H-MRS in major
1
response in major depressive disorder. J Affect Disord. depressive disorder: A Ketamine treatment study.
2013;145(1):115-119. Neuropsychopharmacology. 2018;43(9):1908-1914.
doi: 10.1016/j.jad.2012.05.042 doi: 10.1038/s41386-018-0057-1
39. Rantamaki T, Kohtala S. Encoding, consolidation, and 48. Pothula S, Kato T, Liu RJ, et al. Cell-type specific modulation
renormalization in depression: Synaptic homeostasis, of NMDA receptors triggers antidepressant actions. Mol
plasticity, and sleep integrate rapid antidepressant effects. Psychiatry. 2021;26(9):5097-5111.
Pharmacol Rev. 2020;72(2):439-465.
doi: 10.1038/s41380-020-0796-3
doi: 10.1124/pr.119.018697
49. Miller OH, Moran JT, Hall BJ. Two cellular hypotheses
40. De Diego-Adelino J, Portella MJ, Gomez-Anson B, et al. explaining the initiation of ketamine’s antidepressant actions:
Hippocampal abnormalities of glutamate/glutamine, Direct inhibition and disinhibition. Neuropharmacology.
N-acetylaspartate and choline in patients with depression 2016;100:17-26.
are related to past illness burden. J Psychiatry Neurosci.
2013;38(2):107-116. doi: 10.1016/j.neuropharm.2015.07.028
doi: 10.1503/jpn.110185 50. Moaddel R, Luckenbaugh DA, Xie Y, et al. D-serine plasma
concentration is a potential biomarker of (R,S)-ketamine
41. Draganov M, Vives-Gilabert Y, de Diego-Adelino J, Vicent- antidepressant response in subjects with treatment-resistant
Gil M, Puigdemont D, Portella MJ. Glutamatergic and depression. Psychopharmacology (Berl). 2015;232(2):399-409.
GABA-ergic abnormalities in First-episode depression.
A 1-year follow-up 1H-MR spectroscopic study. J Affect doi: 10.1007/s00213-014-3669-0
Disord. 2020;266:572-577. 51. Ortiz R, Niciu MJ, Lukkahati N, et al. Shank3 as a potential
doi: 10.1016/j.jad.2020.01.138 biomarker of antidepressant response to ketamine and
its neural correlates in bipolar depression. J Affect Disord.
1
42. Benson KL, Bottary R, Schoerning L, et al. H MRS 2015;172:307-311.
measurement of cortical GABA and glutamate in primary
insomnia and major depressive disorder: Relationship doi: 10.1016/j.jad.2014.09.015
to sleep quality and depression severity. J Affect Disord. 52. Tizabi Y, Bhatti BH, Manaye KF, Das JR, Akinfiresoye L.
2020;274:624-631. Antidepressant-like effects of low ketamine dose is associated
doi: 10.1016/j.jad.2020.05.026 with increased hippocampal AMPA/NMDA receptor
density ratio in female Wistar-Kyoto rats. Neuroscience.
43. Wang KL, Liang K, Wang LJ, et al. The association of
glutamate level in pregenual anterior cingulate, anhedonia, 2012;213:72-80.
and emotion-behavior decoupling in patients with major doi: 10.1016/j.neuroscience.2012.03.052
depressive disorder. Asian J Psychiatr. 2022;78:103306. 53. Li N, Lee B, Liu RJ, et al. mTOR-dependent synapse
doi: 10.1016/j.ajp.2022.103306 formation underlies the rapid antidepressant effects of
NMDA antagonists. Science. 2010;329(5994):959-964.
44. Milak MS, Proper CJ, Mulhern ST, et al. A pilot in vivo
proton magnetic resonance spectroscopy study of amino acid doi: 10.1126/science.1190287

Volume 2 Issue 3 (2024) 11 doi: 10.36922/jcbp.2596